Fig. 2.

Analysis of recurrence-free survival (RFS, defined as the time from choroidal melanoma diagnosis to recurrence) according to risk factors for recurrence of primary uveal melanoma (A). (B) Subgroup analysis according to local treatment with ≥ 1 risk factor. CI, confidence interval; N/A, not available. ^a)Includes tumor basal diameter ≥ 15 mm, depth ≥ 10 mm, ^b)Includes brachytherapy, gamma-knife radiotherapy, transpupillary thermotherapy, ^c)Includes trans pars plana vitrectomy, enucleation, excision, exentration.